Investigational. AiMediQ™ and datasyteAI™ are in active development and have not been cleared or approved by the FDA or any regulatory body. Not for clinical use.

    Skip to main content
    PathFree Technologies
    Current page: Investor Inquiry
    Investor relations

    Investor Inquiry

    A dedicated channel for accredited investors, analysts, and prospective partners. Investor communications are handled separately from clinical and technical inquiries.

    Do not include patient information, medical records, or other sensitive health information.

    Do not include patient information, medical records, or other sensitive health information.

    We reply within two business days.